Evidence map›Paper›PMID 30364017›Full record

ArticleOxidative medicine and cellular longevity2018

Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in

Rômulo D Novaes, Eliziária C Santos, Marli C Cupertino, Daniel S S Bastos, Andréa A S Mendonça, Eduardo de Almeida Marques-da-Silva, Sílvia A Cardoso, Juliana L R Fietto, Leandro L Oliveira

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rômulo D NovaesInstitute of Biomedical Sciences, Department of Structural Biology, Federal University of Alfenas, MG, Brazil.ORCID 0000-0002-3186-5328
Eliziária C SantosSchool of Medicine, Federal University of Jequitinhonha and Mucuri Valleys, MG, Brazil.ORCID 0000-0002-3030-7746
Marli C CupertinoDepartament of General Biology, Federal University of Viçosa, MG, Brazil.
Daniel S S BastosDepartament of General Biology, Federal University of Viçosa, MG, Brazil.ORCID 0000-0001-7442-8067
Andréa A S MendonçaInstitute of Biomedical Sciences, Department of Structural Biology, Federal University of Alfenas, MG, Brazil.
Eduardo de Almeida Marques-da-SilvaDepartament of General Biology, Federal University of Viçosa, MG, Brazil.
Sílvia A CardosoDepartment of Medicine and Nursing, Federal University of Viçosa, MG, Brazil.
Juliana L R FiettoDepartment of Biochemistry and Molecular Biology, Federal University of Viçosa, MG, Brazil.ORCID 0000-0001-6122-1710
Leandro L OliveiraDepartament of General Biology, Federal University of Viçosa, MG, Brazil.ORCID 0000-0003-4353-7011
Universidade Federal de Viçosa · BRUniversidade Federal de Alfenas · BRUniversidade Federal dos Vales do Jequitinhonha e Mucuri · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suramin (Sur) acts as an

Indexed as

AnimalsAntioxidantsBiomarkersChagas DiseaseInflammationMaleMice, Inbred C57BLMyocarditisMyocardiumNitric OxideOxidative StressPurinergic AntagonistsSuraminTrypanosoma cruziAntioxidantsBiomarkersNitric OxidePurinergic AntagonistsSuramin

Identifiers

PMID30364017
PMCPMC6186315
OpenAlexW2892874345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.